Literature DB >> 34465889

Ubiquitination of NF-κB p65 by FBXW2 suppresses breast cancer stemness, tumorigenesis, and paclitaxel resistance.

Chune Ren1, Xue Han1, Chao Lu1, Tingting Yang1, Pengyun Qiao1, Yonghong Sun2, Zhenhai Yu3.   

Abstract

The F-box and WD-repeat-containing protein 2 (FBXW2) plays a crucial role as an E3 ligase in regulating tumorigenesis. However, the functions of FBXW2 in breast cancer are still unknown. Here, we find that nuclear factor-kB (NF-κB) p65 is a new substrate of FBXW2. FBXW2 directly binds to p65, leading to its ubiquitination and degradation. Interestingly, p300 acetylation of p65 blocks FBXW2 induced p65 ubiquitination. FBXW2-p65 axis is a crucial regulator of SOX2-induced stemness in breast cancer. Moreover, FBXW2 inhibits breast tumor growth by regulating p65 degradation in vitro and in vivo. FBXW2 overexpression abrogates the effects of p65 on paclitaxel resistance in vitro and in vivo. Furthermore, FBXW2 induced p65 degradation is also confirmed in FBXW2-knockout mice. Our results identify FBXW2 as an important E3 ligase for p65 degradation, which provide insights into the tumor suppressor functions of FBXW2 in breast cancer.
© 2021. The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34465889      PMCID: PMC8816940          DOI: 10.1038/s41418-021-00862-4

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   12.067


  58 in total

1.  Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex.

Authors:  B A Schulman; A C Carrano; P D Jeffrey; Z Bowen; E R Kinnucan; M S Finnin; S J Elledge; J W Harper; M Pagano; N P Pavletich
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

Review 2.  SCF ubiquitin ligase-targeted therapies.

Authors:  Jeffrey R Skaar; Julia K Pagan; Michele Pagano
Journal:  Nat Rev Drug Discov       Date:  2014-11-14       Impact factor: 84.694

3.  RACK1 (receptor for activated C-kinase 1) interacts with FBW2 (F-box and WD-repeat domain-containing 2) to up-regulate GCM1 (glial cell missing 1) stability and placental cell migration and invasion.

Authors:  Chang-Chun Wang; Hsiao-Fan Lo; Shu-Yu Lin; Hungwen Chen
Journal:  Biochem J       Date:  2013-07-15       Impact factor: 3.857

4.  FBXW2 suppresses proliferation and invasion of lung cancer cells by targeting SKP2 and β-catenin.

Authors:  Fei Yang; Yi Sun
Journal:  Mol Cell Oncol       Date:  2019-05-08

Review 5.  Overcoming Endocrine Resistance in Breast Cancer.

Authors:  Ariella B Hanker; Dhivya R Sudhan; Carlos L Arteaga
Journal:  Cancer Cell       Date:  2020-04-13       Impact factor: 31.743

Review 6.  Breast cancer.

Authors:  Nadia Harbeck; Frédérique Penault-Llorca; Javier Cortes; Michael Gnant; Nehmat Houssami; Philip Poortmans; Kathryn Ruddy; Janice Tsang; Fatima Cardoso
Journal:  Nat Rev Dis Primers       Date:  2019-09-23       Impact factor: 52.329

7.  The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.

Authors:  Yuan Yin; Chuan-Ming Xie; Hua Li; Mingjia Tan; Guoan Chen; Rachel Schiff; Xiufang Xiong; Yi Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

Review 8.  Key steps for effective breast cancer prevention.

Authors:  Kara L Britt; Jack Cuzick; Kelly-Anne Phillips
Journal:  Nat Rev Cancer       Date:  2020-06-11       Impact factor: 60.716

9.  The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor.

Authors:  Jie Xu; Weihua Zhou; Fei Yang; Guoan Chen; Haomin Li; Yongchao Zhao; Pengyuan Liu; Hua Li; Mingjia Tan; Xiufang Xiong; Yi Sun
Journal:  Nat Commun       Date:  2017-01-16       Impact factor: 14.919

10.  FBXW2 suppresses migration and invasion of lung cancer cells via promoting β-catenin ubiquitylation and degradation.

Authors:  Fei Yang; Jie Xu; Hua Li; Mingjia Tan; Xiufang Xiong; Yi Sun
Journal:  Nat Commun       Date:  2019-03-27       Impact factor: 14.919

View more
  6 in total

1.  Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway.

Authors:  Qing Robert Miao; Ying Jin; Zhimin Fan; Chang Liu; Sijie Li; Xiaoxiao Zhang; Chunxiang Jin; Baofeng Zhao; Liying Li
Journal:  Cancer Gene Ther       Date:  2022-10-14       Impact factor: 5.854

2.  Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis.

Authors:  Xue Han; Chune Ren; Chao Lu; Pengyun Qiao; Tingting Yang; Zhenhai Yu
Journal:  Cell Death Differ       Date:  2022-03-16       Impact factor: 12.067

Review 3.  Long Noncoding RNA 00472: A Novel Biomarker in Human Diseases.

Authors:  Dan-Yang Ren; Xin-Rong Yuan; Cai-Xia Tu; Jian-Ling Shen; Yun-Wei Li; Ai-Hua Yan; Yi Ru; Hui-Yun Han; Yan-Ming Yang; Yan Liu; Hui-Ying Li
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

Review 4.  Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer.

Authors:  Yu Meng; Huiyan Sun; Yayun Li; Shuang Zhao; Juan Su; Furong Zeng; Guangtong Deng; Xiang Chen
Journal:  Int J Biol Sci       Date:  2022-08-29       Impact factor: 10.750

5.  Phosphorylation of PFKFB4 by PIM2 promotes anaerobic glycolysis and cell proliferation in endometriosis.

Authors:  Chao Lu; Pengyun Qiao; Ruihai Fu; Yadi Wang; Jiayi Lu; Xi Ling; Lu Liu; Yujun Sun; Chune Ren; Zhenhai Yu
Journal:  Cell Death Dis       Date:  2022-09-15       Impact factor: 9.685

6.  GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to paclitaxel by forming a vicious cycle with IGF1/IGF1R signaling pathway.

Authors:  Zhao Liu; Du Meng; Jianling Wang; Hongxin Cao; Peng Feng; Siyu Wu; Na Wang; Chengxue Dang; Peng Hou; Peng Xia
Journal:  Cell Death Dis       Date:  2022-08-30       Impact factor: 9.685

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.